Is Semaglutide Gluten Free?

Does the Wegovy injection contain any gluten-derived ingredients?

A question our prescribers hear most weeks, particularly from patients managing coeliac disease alongside their weight. The short answer is no. The Wegovy subcutaneous injection is a water-based solution. Its listed excipients are disodium phosphate dihydrate, propylene glycol, phenol, and water for injection. None of these are derived from wheat, barley, rye, or any other gluten-containing grain.

The active ingredient itself, semaglutide, is a synthetic GLP-1 receptor agonist produced via recombinant DNA technology using a yeast expression system. If you want a deeper look at the ingredient profile, our page covering whether semaglutide contains gluten walks through the manufacturing process and what the excipient list means in practice. You can also read the full excipient list in the Wegovy SmPC, which is published on the Electronic Medicines Compendium (eMC), the authoritative source for what each pen actually contains.

One practical note: if you receive a different branded presentation or a reformulated batch, the excipient list should still be the same, but it costs nothing to ask the dispensing pharmacist to confirm. That habit is worth keeping for any medicine you take regularly.

Is the Wegovy weight-loss tablet gluten free too?

The Wegovy tablet (approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management) uses a co-formulation with SNAC as the absorption enhancer. SNAC is a synthetic fatty-acid derivative, not a cereal-derived excipient, and the tablet formulation does not list gluten-containing ingredients.

The oral tablet does, however, have strict administration requirements: taken first thing in the morning on an empty stomach, with a small amount of plain water, and nothing else eaten or drunk for at least 30 minutes afterwards. This has nothing to do with gluten, it reflects how SNAC-assisted absorption works across the stomach lining. People sometimes confuse dietary restrictions around the tablet with an ingredient concern; they are separate issues entirely.

For anyone weighing up the injection against the tablet, our Wegovy treatment overview covers both presentations and how a prescriber decides which is appropriate for a given patient.

Should people with coeliac disease take any extra steps?

Having coeliac disease does not automatically rule out semaglutide. The licensed eligibility criteria for Wegovy focus on BMI and weight-related health conditions; coeliac disease itself is not listed as a contraindication. You can find the full licensed conditions and eligibility thresholds summarised by the NHS's semaglutide medicines page.

There are, however, a couple of things worth flagging at the consultation stage. First, gastrointestinal side effects (nausea, loose stools, reduced appetite) are common at treatment initiation and during dose increases. In someone with an already-sensitive gut, those early weeks can feel more pronounced. Second, coeliac disease sometimes affects absorption of other medicines taken alongside semaglutide, so a prescriber who knows your full picture can factor that in.

Separately, if you are wondering whether you can get Wegovy for free, that page explains the NHS criteria and funding routes that may apply to your situation. Understanding whether you qualify before paying privately is worth doing before you commit.

The clearest practical step: bring your coeliac diagnosis to your consultation, list any other medicines or supplements you take, and ask the prescriber directly. That conversation costs nothing and gives you a confident answer tailored to your situation rather than a general one.

Where can you verify the excipient information officially?

The most reliable source is always the current Summary of Product Characteristics (SmPC) or Patient Information Leaflet for the specific product you are dispensed. Both are published on the eMC, updated whenever Novo Nordisk submits a variation to the MHRA. The eMC entry for Wegovy lists excipients in section 6.1; the PIL repeats them in plain language under "What Wegovy contains".

A second route is to ask the dispensing pharmacy directly. A GPhC-registered pharmacy will have access to current product documentation and can confirm whether a specific batch or pen size carries any excipient difference. You can verify that any online pharmacy you use appears on the GPhC register at pharmacyregulation.org/registers; nume's registration number is 9012878.

For more background on semaglutide's licensed uses and how it works, our page covering semaglutide 1 is a useful starting point alongside the semaglutide information page. And if you are exploring how to access Wegovy for free, that page sets out the NHS pathways and what the referral process typically involves.

Ready to talk through your medical history, including any dietary conditions, with a prescriber? Start your free consultation and a GPhC-registered Independent Prescriber will review your answers the same day.